These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15415598)
1. The formation of complement fixing and neutralizing antibodies after the injection of inactivated rabies virus with adjuvants. LIPTON MM; FREUND J J Immunol; 1950 Apr; 64(4):297-303. PubMed ID: 15415598 [No Abstract] [Full Text] [Related]
2. Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants. Shi W; Kou Y; Xiao J; Zhang L; Gao F; Kong W; Su W; Jiang C; Zhang Y Vaccine; 2018 Aug; 36(33):5020-5029. PubMed ID: 30037417 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine. Asgary V; Shoari A; Afshar Moayad M; Shafiee Ardestani M; Bigdeli R; Ghazizadeh L; Khosravy MS; Panahnejad E; Janani A; Bashar R; Abedi M; Ahangari Cohan R Viral Immunol; 2018; 31(1):47-54. PubMed ID: 29328884 [TBL] [Abstract][Full Text] [Related]
4. A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine. Wang X; Bao M; Wan M; Wei H; Wang L; Yu H; Zhang X; Yu Y; Wang L Vaccine; 2008 Mar; 26(15):1893-901. PubMed ID: 18321616 [TBL] [Abstract][Full Text] [Related]
5. Enhanced Immune Response to Rabies Viruses by the Use of a Liposome Adjuvant in Vaccines. Miao L; Yang Y; Yan M; Li Y; Zhao J; Guo J; Zheng D Viral Immunol; 2017 Dec; 30(10):727-733. PubMed ID: 28953450 [TBL] [Abstract][Full Text] [Related]
6. [Complement-fixing rabies antibodies in mice vaccinated and posteriorly challenged]. Oliveira LH; Andrade CM; Reis W An Microbiol (Rio J); 1980; 25():135-47. PubMed ID: 6982627 [No Abstract] [Full Text] [Related]
7. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus. Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031 [TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine. Luo J; Zhang B; Wu Y; Tian Q; Zhao J; Lyu Z; Zhang Q; Mei M; Luo Y; Guo X Vaccine; 2017 Feb; 35(6):938-944. PubMed ID: 28089546 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant activity of Chinese herbal polysaccharides in inactivated veterinary rabies vaccines. Liu Y; Zhang S; Zhang F; Hu R Int J Biol Macromol; 2012 Apr; 50(3):598-602. PubMed ID: 22326819 [TBL] [Abstract][Full Text] [Related]
10. An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers. Wijaya L; Tham CYL; Chan YFZ; Wong AWL; Li LT; Wang LF; Bertoletti A; Low JG Vaccine; 2017 Feb; 35(8):1175-1183. PubMed ID: 28118938 [TBL] [Abstract][Full Text] [Related]
11. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs. Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816 [TBL] [Abstract][Full Text] [Related]
12. Effect of levamisole on the humoral immune response against rabies in cattle. Cazella LN; Pardo PE; Frazatti-Gallina NM; Reis LS Vet Rec; 2009 Dec; 165(24):722-3. PubMed ID: 20008346 [No Abstract] [Full Text] [Related]
13. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults. Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of water-in-oil-in-water multiple emulsion and microemulsion as potential adjuvants for immunization with rabies antigen. Leclercq SY; dos Santos RM; Macedo LB; Campos PC; Ferreira TC; de Almeida JG; Seniuk JG; Serakides R; Silva-Cunha A; Fialho SL Eur J Pharm Sci; 2011 Aug; 43(5):378-85. PubMed ID: 21627989 [TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Re as an adjuvant to enhance the immune response to the inactivated rabies virus vaccine in mice. Su X; Pei Z; Hu S Int Immunopharmacol; 2014 Jun; 20(2):283-9. PubMed ID: 24680943 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein. Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075 [TBL] [Abstract][Full Text] [Related]
17. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. Kaur M; Saxena A; Rai A; Bhatnagar R FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168 [TBL] [Abstract][Full Text] [Related]
18. Alum adjuvanted rabies DNA vaccine confers 80% protection against lethal 50 LD Garg R; Kaur M; Saxena A; Prasad R; Bhatnagar R Mol Immunol; 2017 May; 85():166-173. PubMed ID: 28267643 [TBL] [Abstract][Full Text] [Related]
19. A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen. Kalimuddin S; Wijaya L; Chan YFZ; Wong AWL; Oh HML; Wang LF; Kassim JA; Zhao J; Shi Z; Low JG Vaccine; 2017 Dec; 35(51):7127-7132. PubMed ID: 29174316 [TBL] [Abstract][Full Text] [Related]